PraxyMonitoring – Improve and automate the detection and analysis of pharmacovigilance cases (PV)

​Detection and analysis of cases with unparalleled precision, guaranteed by unique OCR technology and an anti-hallucination system

Why choose our solution?

Pharmacovigilance is a critical issue for patient safety and regulatory compliance. Traditional methods, often manual and prone to errors, are no longer sufficient in the face of increasing data complexity.   

Our solution combines artificial intelligence, state-of-the-art OCR and an exclusive anti-hallucination system to transform the detection and analysis of pharmacovigilance cases.

Our key strengths

Precision and comprehensiveness

Precise extraction of data from PubMed case reports and scientific journals, even from complex documents (PDF, images, handwritten forms). Reduction of input errors and time savings.

Anti-hallucination system

Elimination of false positives and guarantee of reliable results, compliant with MedDRA and regulatory standards.

Intelligent automation

Proactive detection of safety signals, prioritisation of critical cases and real-time report generation.

Enhanced compliance

Alignment with agency requirements (HAS, EMA, FDA, etc.), following typing standards (e.g. MedDRA) and reduction of non-compliance risks. 

Predictive analysis

Early identification of trends and emerging risks thanks to IA algorithms trained on global databases.

A unique technology for flawless pharmacovigilance

1. Next-generation OCR: precision and comprehensiveness

Unlike classic solutions that struggle to process unstructured documents, our OCR optimised for pharmacovigilance:

• Recognises and extracts data from the most varied sources: clinical reports, handwritten declarations, scientific publications, social media, etc.
• Reduces transcription errors thanks to continuous learning adapted to medical terminologies (MedDRA, WHO-DDE, etc.).
• Integrates automatic validation to ensure data integrity before analysis.

Example: A scanned or photographed adverse event report is processed in real time, with an accuracy of over 99%, compared to 80-85% for standard tools.

2. Anti-hallucination system: 100% reliable results

Traditional AI solutions can generate incorrect interpretations ("hallucinations"), jeopardising patient safety and compliance. Our technology:

• Checks each piece of data by cross-referencing multiple sources and applying strict business rules.
• Eliminates bias thanks to a model trained on millions of cases validated by experts.
• Provides complete traceability for each decision, essential in the event of an audit.

Comparison: Where other tools may suggest incorrect links between a drug and an adverse event, our system only proposes correlations backed by evidence.

3. Intelligent workflow automation

From detection to reporting, our platform covers the entire process:

• Automated data collection (public databases, EHR, CRM, etc.).
• Sorting and prioritisation of cases based on their severity (algorithms inspired by EMA and FDA best practices).
• Generation of reports compliant with regulatory formats (ICSR, PSUR, RMP), ready to be submitted to authorities.

Time savings: Up to 70% reduction in time spent on repetitive tasks, allowing your teams to focus on strategic analysis.

Why choose Praxy.ai?

How we differentiate ourselves from the competition

Concrete use cases

1. Early detection of safety signals

• Problem : A rare adverse effect is reported in unstructured clinical reports and goes unnoticed.
• Our solution : OCR identifies and extracts the information, while AI corroborates it with other sources (social media, literature). The anti-hallucination system validates the signal before alerting.
• Result : 50% reduction in detection time compared to manual review.

2. Management of spontaneous reports

• Problem : Handwritten or oral reports (via call centres) are sources of errors.
• Our solution : Automatic transcription + AI validation, with direct integration into your database.
• Result : 90% of reports processed without human intervention, with an error rate close to zero.

3. Audit and compliance

• Problem : Preparing a regulatory audit takes weeks.
• Our solution : Instant generation of traceable reports, with attached documentary evidence.
• Result : 40% reduction in audit costs and elimination of non-compliance risks.

For whom?

Our solution is aimed at:

• Pharmaceutical laboratories : To accelerate risk detection and optimise pharmacovigilance costs.
• CRO (Contract Research Organizations) : To offer a differentiating service to their clients.
• Health authorities : To strengthen post-marketing surveillance.
• Hospitals and clinical centres : To improve adverse effect reporting.

Testimonials and results

« In the pilot phase, a comparison of 1 million activities showed that AI detected more confirmed PV cases, with very few false alerts »

Request a demo

Discover how our technology can revolutionise your pharmacovigilance with :

• Faster risk detection.
• 100% reliable data.
• Effortless compliance.

📅 Plan a demo 📩 Contact us

Q&A

Q : How do you guarantee data confidentiality ? R : Our platform is hosted on ISO 27001 and HIPAA certified servers, with end-to-end encryption.

Q : Is your solution compatible with our existing tools (Veeva, Argus, etc.) ? R : Yes, we offer ready-to-use connectors and an API for custom integration.

Q : What is the expected ROI ? R : Our clients observe an average return on investment in less than 12 months, thanks to productivity gains and reduced non-compliance costs.